Annual Drug Patent Expirations for ODEFSEY
Odefsey is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are ten patents protecting this drug.
Drug patent litigation for ODEFSEY.
This drug has three hundred and thirty-two patent family members in fifty-seven countries.
The generic ingredient in ODEFSEY is emtricitabine; rilpivirine hydrochloride; tenofovir alafenamide fumarate. One supplier is listed for this compound. Additional details are available on the emtricitabine; rilpivirine hydrochloride; tenofovir alafenamide fumarate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
